EPIC-Oxford 2

  • Research type

    Research Study

  • Full title

    EPIC-Oxford 2

  • IRAS ID

    359674

  • Contact name

    Keren Papier

  • Contact email

    keren.papier@ndph.ox.ac.uk

  • Sponsor organisation

    University of Oxford

  • Duration of Study in the UK

    2 years, 11 months, 31 days

  • Research summary

    EPIC-Oxford 2 is a UK study investigating the long-term health effects of different diets, including plant-based diets that contain little or no animal products. While such diets may benefit health through lower saturated fat and higher fibre, they may also be low in nutrients such as iron, vitamin B12, calcium, or high-quality protein, which could increase risks for certain conditions.

    The study builds on the original EPIC-Oxford cohort, established 30 years ago with 65,000 participants, about half of whom did not eat meat. The resource includes detailed dietary information, stored blood samples, and long-term linkage to NHS records on hospital admissions, cancer diagnoses, and deaths.

    EPIC-Oxford 2 will resurvey surviving participants and recruit up to 80,000 new participants, aiming to include more vegans and increase ethnic diversity. Participants will complete online questionnaires about their diet and lifestyle, provide optional blood samples, and repeat dietary assessments at regular intervals. Health outcomes will be tracked through NHS record linkage and managed via the UK Longitudinal Linkage Collaboration (UK LLC), which will provide secure access for approved researchers.

    Participation is entirely voluntary, and individuals may choose whether to take part in any component. The study will create a rich, long-term resource to provide reliable information on the effects of plant-based diet, other dietary and lifestyle factors, and data derived from biological samples, on measures of health.

  • REC name

    South West - Frenchay Research Ethics Committee

  • REC reference

    26/SW/0076

  • Date of REC Opinion

    5 Aug 2026

  • REC opinion

    Further Information Favourable Opinion